Meridian Financial Partners’s AbbVie ABBV Stock Holding History

Meridian Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$387K	Hold	1,585	–	–	0.13%	90
2026 Q1	$327K	Buy	1,585 +3	+0.2%	+$665	0.12%	90
2025 Q4	$342K	Buy	1,582 +9	+0.6%	+$2.05K	0.14%	87
2025 Q3	$364K	Buy	1,573 +9	+0.6%	+$1.83K	0.15%	83
2025 Q2	$290K	Buy	1,564 +1	+0.1%	+$186	0.14%	89
2025 Q1	$327K	Sell	1,563 -160	-9%	-$31.1K	0.17%	83
2024 Q4	$306K	Hold	1,723	–	–	0.16%	80
2024 Q3	$340K	Sell	1,723 -36	-2%	-$6.72K	0.17%	79
2024 Q2	$301K	Hold	1,759	–	–	0.18%	69
2024 Q1	$286K	Buy	1,759 +40	+2%	+$6.89K	0.37%	34
2023 Q4	$281K	Buy	+1,719	New	+$251K	0.29%	43
2023 Q2	–	Sell	-1,325	Closed	-$211K	–	87
2023 Q1	$211K	Sell	1,325 -4,330	-77%	-$662K	0.24%	44
2022 Q4	$841K	Sell	5,655 -6	-0.1%	-$920	0.95%	27
2022 Q3	$809K	Buy	5,661 +389	+7%	+$55.8K	1.15%	23
2022 Q2	$797K	Buy	5,272 +151	+3%	+$23.1K	0.54%	47
2022 Q1	$830K	Buy	5,121 +76	+2%	+$11K	1.24%	23
2021 Q4	$682K	Buy	+5,045	New	+$596K	0.46%	46

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Meridian Financial Partners's ABBV Position: Q2 2026 in Review

Meridian Financial Partners held its AbbVie (ABBV) position steady in Q2 2026 at 1,585 shares worth $387K. The position accounts for 0.13% of the portfolio, ranked #90.

Meridian Financial Partners first reported a position in ABBV in Q4 2021 and has held it in 17 quarters since. The position peaked at $841K in Q4 2022. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Meridian Financial Partners held 1,585 shares of AbbVie worth $387K as of Q2 2026.
Meridian Financial Partners left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.13% of Meridian Financial Partners's portfolio in Q2 2026, its #90 holding.
Meridian Financial Partners first reported a position in AbbVie in Q4 2021 and has held it in 17 quarters since.
Meridian Financial Partners's AbbVie position peaked at $841K in Q4 2022.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Meridian Financial Partners's 13F filing for Q2 2026, filed 24 Jul 2026.